ClinicalTrials.gg
CompletedNCT01004068Updated Nov 3, 2010

Short-term Structured Exercise Training Program Plus Diet Intervention in Patients With Polycystic Ovary Syndrome (PCOS)

A Phase 4 interventional study of SET-diet plus clomiphene and Clomiphene citrate in Polycystic Ovary Syndrome and Anovulation, sponsored by University Magna Graecia. Completed at 1 site in Italy. Open to female participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2010-11-03.

Sponsored by University Magna Graecia · Phase 4, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
96
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 16 studies in Polycystic Ovary Syndrome by University Magna Graecia — none open to participants now, none under way, none of them phase 3. Polycystic Ovary Syndrome · University Magna Graecia.

Enrollment
3rd of 15
96 · median 50
Started
2008
with 2 others
Phase 4
14 of 16
none open now
Registered
11th of 16
by date

Among the 16 studies in Polycystic Ovary Syndrome by University Magna Graecia, this one is the 3rd largest by enrollment of the 15 interventional ones that give a count, is one of 3 that started in 2008, is one of 14 in phase 4, and was the 11th registered.

Polycystic Ovary Syndrome

959 studies on the registry are indexed under Polycystic Ovary Syndrome; 176 are open to participants now.

Browse Polycystic Ovary Syndrome studies →

Open to participants now

None of the 16 studies in Polycystic Ovary Syndrome by University Magna Graecia is open now. The open studies under Polycystic Ovary Syndrome, anywhere →

Where they have run

Who these studies take

Of the 120 Polycystic Ovary Syndrome studies recruiting now, 11 (9%) set no upper age limit and 106 (88%) stop at 75 or younger; 23 take children under 18; 41 take healthy volunteers.

This study: 18 Years to 35 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Download CSVNarrow it in search →With an account: the 16 studies in Polycystic Ovary Syndrome by University Magna Graecia as a file.
02

Study summary

Clomiphene citrate (CC) is the first-line therapy for infertile women with polycystic ovary syndrome (PCOS). Unfortunately, at least 20% of PCOS results are not responsive to CC. Structured exercise training (SET) and diet has been successfully employed to restore ovarian function and to improve reproductive outcomes in obese and overweight women with PCOS. The current study was aimed to test the hypothesis that a short-term SET program plus diet intervention can improve the ovarian response to CC in CC-resistant PCOS patients.

Read the detailed description

Ninety-six PCOS patients considered CC-resistant because not responsive to 150 mg daily of CC were randomized in three arms (group A, B, and C). Group A underwent SET program plus hypocaloric diet for two months, group B had one month of observation followed by one-cycle of CC therapy, and group C underwent SET program plus hypocaloric diet for two months and received one-cycle of CC for one cycle. CC was always given at the maximal dose previously used. Clinical, hormonal and metabolic data were assessed at baseline and after intervention. Ovulation was monitored by ultrasound and confirmed by plasma progesterone assay.

03

Conditions studied

  • Polycystic Ovary Syndrome
  • Anovulation

Keywords

  • Clomiphene
  • Diet
  • Exercise
  • Infertility
  • PCOS
  • Physical activity
  • Treatment
04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • PCOS
  • Anovulation

Exclusion criteria

Exclusion Criteria:

  • Major Medical Condition
  • Severe Obesity
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
96 participants (actual)

Study arms

  • Experimental
    SET-diet plus clomiphene

    Structured exercise program plus hypocaloric diet for two months and received one-cycle of clomiphene citrate for one cycle

    Other: SET-diet plus clomiphene

  • Active comparator
    Clomiphene citrate

    One month of observation followed by one-cycle of clomiphene citrate therapy

    Drug: Clomiphene citrate

  • Experimental
    SET plus diet

    Lifestyle modifications for two months.

    Behavioral: Structured exercise program plus hypocaloric diet

Interventions

  • OtherSET-diet plus clomiphene

    Two months of structured exercise program plus hypocaloric diet followed by 150 mg daily of clomiphene citrate

    Also known as: Lifestyle modification, CC

  • DrugClomipheneStudies of ClomipheneClomiphene pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Clomiphene citrate at 150 mg daily for one cycle

    Also known as: CC

  • BehavioralStructured exercise program plus hypocaloric diet

    SET plus diet

    Also known as: Lifestyle modifications

06

What researchers measure

Primary outcomes

  1. Ovulation rate

    Time frame: three months

Secondary outcomes

  1. Clinical data

    Time frame: three months

  2. Metabolic data

    Time frame: three months

07

Study locations

1 site
  • "Pugliese" Hospital
    Catanzaro, 88100, Italy
08

References and documents

Publications

  • Vigorito C, Giallauria F, Palomba S, Cascella T, Manguso F, Lucci R, De Lorenzo A, Tafuri D, Lombardi G, Colao A, Orio F. Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007 Apr;92(4):1379-84. doi: 10.1210/jc.2006-2794. Epub 2007 Jan 30. PubMed 17264174 ↗
  • Palomba S, Giallauria F, Falbo A, Russo T, Oppedisano R, Tolino A, Colao A, Vigorito C, Zullo F, Orio F. Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study. Hum Reprod. 2008 Mar;23(3):642-50. doi: 10.1093/humrep/dem391. Epub 2007 Dec 23. PubMed 18158291 ↗
  • Palomba S, Falbo A, Giallauria F, Russo T, Rocca M, Tolino A, Zullo F, Orio F. Six weeks of structured exercise training and hypocaloric diet increases the probability of ovulation after clomiphene citrate in overweight and obese patients with polycystic ovary syndrome: a randomized controlled trial. Hum Reprod. 2010 Nov;25(11):2783-91. doi: 10.1093/humrep/deq254. Epub 2010 Sep 21. PubMed 20858697 ↗
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Feb 2008, a primary completion of Oct 2009 and a completion of Oct 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 15, 2009
First posted
Oct 29, 2009
Start
Feb 2008
Primary completionActual
Oct 2009
CompletionActual
Oct 2009
Last update
Nov 3, 2010
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 3, 2010, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01004068
Lead sponsor
University Magna Graecia
First posted
Oct 29, 2009
Start date
Feb 2008
Primary completion
Oct 2009
Completion
Oct 2009
Last update
Nov 3, 2010

Study contacts

Stefano Palomba, MD
principal investigator · University Magna Graecia

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2009. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion